Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease

Sui Lung Su, Wei Teing Chen, Po Jen Hsiao, Kuo Cheng Lu, Yuh Feng Lin, Chin Lin, Wen Su, Shih Jen Yeh, Hung Chang, Fu Huang Lin

研究成果: 雜誌貢獻文章

摘要

Single nucleotide polymorphisms (SNPs) in renin-angiotensin system (RAS) genes are associated with RAS imbalance and chronic kidney disease (CKD). We performed a case-control study and meta-analysis to investigate the association between angiotensinogen (AGT) M235T polymorphism and CKD. A total of 634 patients with end-stage renal disease and 739 healthy controls were studied. We also searched PubMed and the Cochrane Library to identify prospective observational studies published before December 2015. We found that the TT and MT genotypes were associated with a higher risk of CKD than the MM genotype (odds ratio [OR]: 3.56; 95% confidence interval [CI]: 1.14-11.16 and OR: 2.93; 95% CI: 0.91-9.46, respectively). Thirty-eight study populations were included in the meta-analysis. The T allele was associated with a higher risk of CKD than the M allele in all populations (OR: 1.19; 95% CI: 1.08-1.32). The OR was 1.33 in Asians (95% CI: 1.06-1.67) and 1.10 in Caucasians (95% CI: 1.02-1.18). Evaluation of gene-gene and geneenvironment interactions using epistasis analysis revealed an interaction between AGT M235T and angiotensin II receptor type 1 A1166C in CKD (OR: 0.767; 95% CI: 0.609-0.965). Genetic testing for CKD in high-risk individuals may be an effective strategy for CKD prevention.

原文英語
頁(從 - 到)107833-107843
頁數11
期刊Oncotarget
8
發行號64
DOIs
出版狀態已發佈 - 一月 1 2017

指紋

Angiotensinogen
Angiotensin Type 1 Receptor
Chronic Renal Insufficiency
Confidence Intervals
Odds Ratio
Renin-Angiotensin System
Meta-Analysis
Alleles
Genotype
Genes
Genetic Testing
PubMed
Population
Libraries
Chronic Kidney Failure
Observational Studies
Single Nucleotide Polymorphism
Case-Control Studies
Prospective Studies

ASJC Scopus subject areas

  • Oncology

引用此文

Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease. / Su, Sui Lung; Chen, Wei Teing; Hsiao, Po Jen; Lu, Kuo Cheng; Lin, Yuh Feng; Lin, Chin; Su, Wen; Yeh, Shih Jen; Chang, Hung; Lin, Fu Huang.

於: Oncotarget, 卷 8, 編號 64, 01.01.2017, p. 107833-107843.

研究成果: 雜誌貢獻文章

Su, SL, Chen, WT, Hsiao, PJ, Lu, KC, Lin, YF, Lin, C, Su, W, Yeh, SJ, Chang, H & Lin, FH 2017, 'Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease', Oncotarget, 卷 8, 編號 64, 頁 107833-107843. https://doi.org/10.18632/oncotarget.22121
Su, Sui Lung ; Chen, Wei Teing ; Hsiao, Po Jen ; Lu, Kuo Cheng ; Lin, Yuh Feng ; Lin, Chin ; Su, Wen ; Yeh, Shih Jen ; Chang, Hung ; Lin, Fu Huang. / Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease. 於: Oncotarget. 2017 ; 卷 8, 編號 64. 頁 107833-107843.
@article{63cb09ba8804408788c9524b3efb2f73,
title = "Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease",
abstract = "Single nucleotide polymorphisms (SNPs) in renin-angiotensin system (RAS) genes are associated with RAS imbalance and chronic kidney disease (CKD). We performed a case-control study and meta-analysis to investigate the association between angiotensinogen (AGT) M235T polymorphism and CKD. A total of 634 patients with end-stage renal disease and 739 healthy controls were studied. We also searched PubMed and the Cochrane Library to identify prospective observational studies published before December 2015. We found that the TT and MT genotypes were associated with a higher risk of CKD than the MM genotype (odds ratio [OR]: 3.56; 95{\%} confidence interval [CI]: 1.14-11.16 and OR: 2.93; 95{\%} CI: 0.91-9.46, respectively). Thirty-eight study populations were included in the meta-analysis. The T allele was associated with a higher risk of CKD than the M allele in all populations (OR: 1.19; 95{\%} CI: 1.08-1.32). The OR was 1.33 in Asians (95{\%} CI: 1.06-1.67) and 1.10 in Caucasians (95{\%} CI: 1.02-1.18). Evaluation of gene-gene and geneenvironment interactions using epistasis analysis revealed an interaction between AGT M235T and angiotensin II receptor type 1 A1166C in CKD (OR: 0.767; 95{\%} CI: 0.609-0.965). Genetic testing for CKD in high-risk individuals may be an effective strategy for CKD prevention.",
keywords = "Chronic kidney disease, Polymorphism, Renin-angiotensin system",
author = "Su, {Sui Lung} and Chen, {Wei Teing} and Hsiao, {Po Jen} and Lu, {Kuo Cheng} and Lin, {Yuh Feng} and Chin Lin and Wen Su and Yeh, {Shih Jen} and Hung Chang and Lin, {Fu Huang}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.22121",
language = "English",
volume = "8",
pages = "107833--107843",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "64",

}

TY - JOUR

T1 - Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease

AU - Su, Sui Lung

AU - Chen, Wei Teing

AU - Hsiao, Po Jen

AU - Lu, Kuo Cheng

AU - Lin, Yuh Feng

AU - Lin, Chin

AU - Su, Wen

AU - Yeh, Shih Jen

AU - Chang, Hung

AU - Lin, Fu Huang

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Single nucleotide polymorphisms (SNPs) in renin-angiotensin system (RAS) genes are associated with RAS imbalance and chronic kidney disease (CKD). We performed a case-control study and meta-analysis to investigate the association between angiotensinogen (AGT) M235T polymorphism and CKD. A total of 634 patients with end-stage renal disease and 739 healthy controls were studied. We also searched PubMed and the Cochrane Library to identify prospective observational studies published before December 2015. We found that the TT and MT genotypes were associated with a higher risk of CKD than the MM genotype (odds ratio [OR]: 3.56; 95% confidence interval [CI]: 1.14-11.16 and OR: 2.93; 95% CI: 0.91-9.46, respectively). Thirty-eight study populations were included in the meta-analysis. The T allele was associated with a higher risk of CKD than the M allele in all populations (OR: 1.19; 95% CI: 1.08-1.32). The OR was 1.33 in Asians (95% CI: 1.06-1.67) and 1.10 in Caucasians (95% CI: 1.02-1.18). Evaluation of gene-gene and geneenvironment interactions using epistasis analysis revealed an interaction between AGT M235T and angiotensin II receptor type 1 A1166C in CKD (OR: 0.767; 95% CI: 0.609-0.965). Genetic testing for CKD in high-risk individuals may be an effective strategy for CKD prevention.

AB - Single nucleotide polymorphisms (SNPs) in renin-angiotensin system (RAS) genes are associated with RAS imbalance and chronic kidney disease (CKD). We performed a case-control study and meta-analysis to investigate the association between angiotensinogen (AGT) M235T polymorphism and CKD. A total of 634 patients with end-stage renal disease and 739 healthy controls were studied. We also searched PubMed and the Cochrane Library to identify prospective observational studies published before December 2015. We found that the TT and MT genotypes were associated with a higher risk of CKD than the MM genotype (odds ratio [OR]: 3.56; 95% confidence interval [CI]: 1.14-11.16 and OR: 2.93; 95% CI: 0.91-9.46, respectively). Thirty-eight study populations were included in the meta-analysis. The T allele was associated with a higher risk of CKD than the M allele in all populations (OR: 1.19; 95% CI: 1.08-1.32). The OR was 1.33 in Asians (95% CI: 1.06-1.67) and 1.10 in Caucasians (95% CI: 1.02-1.18). Evaluation of gene-gene and geneenvironment interactions using epistasis analysis revealed an interaction between AGT M235T and angiotensin II receptor type 1 A1166C in CKD (OR: 0.767; 95% CI: 0.609-0.965). Genetic testing for CKD in high-risk individuals may be an effective strategy for CKD prevention.

KW - Chronic kidney disease

KW - Polymorphism

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=85037367390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037367390&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.22121

DO - 10.18632/oncotarget.22121

M3 - Article

AN - SCOPUS:85037367390

VL - 8

SP - 107833

EP - 107843

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 64

ER -